The cost of schizophrenia in Japan
Mitsuhiro Sado,1 Ataru Inagaki,2 Akihiro Koreki,1 Martin Knapp,3 Lee Andrew Kissane,4 Masaru Mimura,1 Kimio Yoshimura4 1Department of Neuropsychiatry, Keio University School of Medicine, 2Center for Clinical Psychopharmacology, Institute of Neuropsychiatry, Tokyo, Japan; 3Department of Social Policy...
Guardado en:
Autores principales: | Sado M, Inagaki A, Koreki A, Knapp M, Kissane LA, Mimura M, Yoshimura K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d466e16dfe2a49bb9518578ce2268467 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Influence of patient characteristics on care time in patients hospitalized with schizophrenia
por: Sugibayashi Y, et al.
Publicado: (2014) -
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano J, et al.
Publicado: (2013) -
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
por: Takahashi M, et al.
Publicado: (2012) -
Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients
por: Yoshimura B, et al.
Publicado: (2013) -
Health care resource use and direct medical costs for patients with schizophrenia in Tianjin, People’s Republic of China
por: Wu J, et al.
Publicado: (2015)